Sanofi SA


Sanofi To Snap Up Kymab For Up To $1.45B; Street Sees 25% Upside

Sanofi has entered into an agreement to buy Kymab for up to $1.45 billion in a move to expand the French drugmaker’s pipeline …

EU In Talks With Moderna, BioNtech, CureVac For Potential Covid-19 Vaccine Deals

The European Union is reportedly in talks to make advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna (MRNA), Sanofi (SNY) and …

Regeneron, Sanofi Get FDA Nod For Dupixent Treatment In Children

Drug companies Regeneron Pharmaceuticals, Inc (REGN) and Sanofi announced that the U.S.

Sanofi CEO Says Americans to Get Potential Virus Vaccine First

French drugmaker Sanofi (SNY) said that the U.S.

Company Update (NASDAQ:REGN): Regeneron Pharmaceuticals Inc and Sanofi SA (ADR) Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that the European Commission (EC) has granted marketing authorization for Praluent® (alirocumab) for the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts